Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Dr. Reddy's Laboratories Ltd (RDY) had Weighted-Average Shares Outstanding (Diluted) of 834.30M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$986.31M |
|
$166.77M |
|
$407.50M |
|
$578.81M |
|
$765.42M |
|
$220.90M |
|
$0.26M |
|
$221.16M |
|
$221.16M |
|
$165.65M |
|
$165.65M |
|
$165.65M |
|
$165.65M |
|
$220.90M |
|
$273.90M |
|
833.31M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
834.30M |
$0.20 |
|
$0.20 |
|
| Balance Sheet Financials | |
$2.96B |
|
$1.09B |
|
$2.67B |
|
$5.62B |
|
$1.54B |
|
$89.00M |
|
$322.00M |
|
$1.86B |
|
$3.76B |
|
$2.53B |
|
$3.76B |
|
834.42M |
|
| Cash Flow Statement Financials | |
$286.00M |
|
$-523.00M |
|
$307.00M |
|
$83.00M |
|
$152.00M |
|
$69.00M |
|
$4.00M |
|
$-78.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.92 |
|
-- |
|
-- |
|
0.02 |
|
0.16 |
|
58.68% |
|
22.40% |
|
22.40% |
|
-- |
|
22.42% |
|
16.91% |
|
$60.00M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.49 |
|
0.91 |
|
98.37 |
|
4.41% |
|
6.54% |
|
2.95% |
|
4.30% |
|
$4.50 |
|
$0.07 |
|
$0.34 |
|